Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of surgery vs chemotherapy in advanced ovarian cancer
2007-004429-45Phase 3Completed
- Sponsor
- Medical Research Council
- Start
- Oct 2007
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of carboplatin and paclitaxel in ovarian cancer, primary peritoneal cancer (PPC) and fallopian tube cancer (PFTC) (2 arms), sponsored by Medical Research Council. Primary endpoint: overall survival. Started Oct 2007; status: completed.
02
Drugs
carboplatinpaclitaxel
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on 2007-004429-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004429-45.